Condition

Colonic Neoplasms

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 15 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials15
Recruiting3
Common interventions25
Lead sponsors shown13
Advertisement

Clinical trials

15 shown
Laparoscopic Versus Open Surgery for Colon Cancer With Visceral ObesityNCT07314996 · 2026-01-18
RECRUITING
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaNCT06885697 · 2025-07-08
RECRUITING
PRE-ISPY Phase I/II Oncology Platform ProgramNCT05868226 · 2023-02-15
RECRUITING
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsNCT05068180 · 2021-10-05
UNKNOWN
A Study of ASN007 in Patients With Advanced Solid TumorsNCT03415126 · 2018-01-19
COMPLETED
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsNCT03037385 · 2017-03-17
COMPLETED
End-of-Life Care for African AmericansNCT02320123 · 2016-05-23
COMPLETED
PERCIST Criteria for Response Evaluation With Solid TumorsNCT02765620 · 2016-04-01
UNKNOWN
Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane AnesthesiaNCT01975064 · 2013-11-01
COMPLETED
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR InhibitorsNCT01137162 · 2008-08-01
TERMINATED
Effect of High-Legume Diet on Colorectal Cancer RiskNCT00339469 · 2005-08-03
COMPLETED
MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.NCT00147550 · 2004-02-01
TERMINATED
A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabNCT00001805 · 1999-03-01
COMPLETED
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial CancersNCT00579163 · 1994-12-01
ACTIVE_NOT_RECRUITING
Women's Health Initiative (WHI)NCT00000611
COMPLETED

Common interventions

ALX148DRUG1ASN007 RDDRUG1ASN007: ascending dosesDRUG1calciumDRUG1cyclophosphamideDRUG1diet, fat-restrictedBEHAVIORAL1dietary supplementsBEHAVIORAL1drug&radiationOTHER1Educational DVDBEHAVIORAL1estrogen replacement therapyDRUG1estrogensDRUG1Fam-Trastuzumab Deruxtecan-NxkiDRUG1fludarabineDRUG1hormone replacement therapyDRUG1Laparoscopic surgeryPROCEDURE1LIFEDIETARY_SUPPLEMENT1low-dose neuroleptanalgesiaDRUG1mesothelin expression testingDEVICE1Open surgeryPROCEDURE1PD-0325901DRUG1PlaceboDRUG1pralsetinib (BLU-667)DRUG1progestinsDRUG1PropofolDRUG1RituximabDRUG1

Trial status mix

COMPLETED7
RECRUITING3
TERMINATED2
UNKNOWN2
ACTIVE_NOT_RECRUITING1

Phase mix

PHASE15
PHASE24
NA2
PHASE42
EARLY_PHASE11
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.